E
OptimizeRx Corporation OPRX
$7.77 $0.628.67%
Recommendation
Sell
Prev Close
$7.77
Volume
1,073,240
Avg Vol (90D)
463,439
Market Cap
$143.38M
Dividend & Yield
--
52-Week Range
$3.78 - $14.13
P/E (TTM)
--
EPS (TTM)
-$1.34
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
OptimizeRx (NASDAQ:OPRX) Upgraded at B. Riley
3/15/2025 - MarketBeat
OptimizeRx (OPRX, $7.77) Stochastic Oscillator left the overbought zone on March 14, 2025
3/15/2025 - Tickeron - Technical Analysis
OptimizeRx (OPRX, $7.15) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 13, 2025
3/14/2025 - Tickeron - Stocks
OptimizeRx (OPRX, $7.15) RSI Indicator left the overbought zone on March 13, 2025
3/14/2025 - Tickeron - Stocks
OptimizeRx (NASDAQ:OPRX) Issues Quarterly Earnings Results
3/13/2025 - MarketBeat
OptimizeRx (OPRX, $6.28) price may drop as it broke higher Bollinger Band on Mar 12, 2025
3/13/2025 - Tickeron - Stocks
OptimizeRx (OPRX, $6.28) RSI Indicator left the oversold zone on March 12, 2025
3/13/2025 - Tickeron - Stocks
OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion
3/13/2025 - GuruFocus
Q4 2024 OptimizeRx Corp Earnings Call Transcript
3/13/2025 - GuruFocus
Optimizerx Exceeds Expectations: Positive Earnings Call
3/13/2025 - TipRanks Financial Blog
Noteworthy Wednesday Option Activity: OPRX, TBCH, MATV
3/12/2025 - Stock Options Channel
OptimizeRx Q4 results 'at odds with muted' outlook, says Roth MKM
3/12/2025 - TipRanks Financial Blog
OptimizeRx Q4 results 'at odds with muted' outlook, says Roth MKM
3/12/2025 - The Fly
OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript
3/12/2025 - Seeking Alpha: Transcripts
OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript
3/12/2025 - SeekingAlpha
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates
3/12/2025 - Zacks Investment Research
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
3/12/2025 - GuruFocus
OptimizeRx sees FY25 adjusted EBITDA at least $12M
3/12/2025 - The Fly
OptimizeRx reports Q4 EPS 30c, consensus 27c
3/12/2025 - The Fly
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
3/12/2025 - Globe Newswire
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
3/11/2025 - GuruFocus
OptimizeRx confirms receipt of notice of director nominations
3/11/2025 - Seeking Alpha - Healthcare
OptimizeRx confirms receipt of notice of director nominations
3/11/2025 - SeekingAlpha.com: All News
OptimizeRx (OPRX, $4.3) RSI Indicator left the oversold zone on March 10, 2025
3/11/2025 - Tickeron - Stocks
OptimizeRx confirems receipt of notice of director nominations
3/11/2025 - The Fly
Income Statement
Total Revenue (TTM)
$88.18M
EBITDA (TTM)
-$4.13M
EBIT (TTM)
-$8.16M
Net Income (TTM)
-$24.17M
Balance Sheet
Total Assets (Q)
$165.20M
Total Debt (Q)
$35.72M
Total Liabilities (Q)
$50.73M
Book Value Per Share (Q)
$6.25
Cash Flow
Cash from Operations (TTM)
-$1.57M
Cash from Investing (TTM)
-$26.33M
Cash from Financing (TTM)
$34.10M
Net Change in Cash (TTM)
$6.21M
Filings
Filing Date
Thursday, November 14, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Apr 14 and 18 (est)
Price History
Created with Highstock 5.0.1411. Nov25. Nov9. Dec23. Dec6. Jan20. Jan3. Feb17. Feb3. Mar$2.00$4.00$6.00$8.00$10.00Price as of Mar 14, 2025
Beta
1.63
7-Day Total Return
64.62%
30-Day Total Return
40.00%
60-Day Total Return
46.05%
90-Day Total Return
50.87%
Year to Date Total Return
49.14%
1-Year Total Return
-38.77%
2-Year Total Return
-39.95%
3-Year Total Return
-78.82%
5-Year Total Return
15.80%
52-week Low
Nov 15, 2024 - $3.78
52-week High
May 15, 2024 - $14.13
Valuation
Market Cap
$143.38M - Micro Cap
Enterprise Value
$163.20M
Price/Sales (TTM)
1.61
Price/Book (Q)
1.24
Dividends and Shares
Shares Outstanding
18.32M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.optimizerx.com
Phone Number
248-651-6568
Address
260 Charles Street
Waltham, MA 02453
Country
United States
Year Founded
2006
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures... more
NASDAQ 03/14/2025 4:00PM Eastern Quotes delayed
Weiss Ratings